Successful treatment of pyoderma gangrenosum with Janus kinase 1/2 inhibition
Abstract Pyoderma gangrenosum (PG) is a rare, autoinflammatory disease leading to painful, hard‐to‐treat ulcers. Besides systemic glucocorticoids, a plethora of classic immunosuppressants, biologics and small molecules have been reported to improve PG disease course. However, often several treatment...
Saved in:
Main Authors: | Sebastian Sitaru (Author), Tilo Biedermann (Author), Felix Lauffer (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful long‐term treatment of pyoderma gangrenosum with secukinumab
by: Fabienne Froehlich, et al.
Published: (2023) -
Pyoderma Gangrenosum
by: Krishnan S G S, et al.
Published: (1997) -
Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
by: Julia D. Stiegler, MD, et al.
Published: (2017) -
Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
by: Danielle Rogner, et al.
Published: (2022) -
Treatment of pyoderma gangrenosum with apremilast monotherapy
by: Zachary A. Bordeaux, BS, et al.
Published: (2022)